Anbio Biotechnology Class A Ordinary Shares (NNNN) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Anbio Biotechnology Class A Ordinary Shares (NNNN) operates in the Healthcare sector, specifically the Medical - Instruments & Supplies industry, with a market capitalization near $400.3M, listed on NASDAQ, employing roughly 27 people, carrying a beta of 5.10 to the broader market. Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. Led by Michael Lau, public since 2025-02-19.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for NNNN as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →